Home ALL Evaluating global medical cannabis regulatory regimes: Lessons to be learned for the UK MCWGmedical cannabisreport Evaluating global medical cannabis regulatory regimes: Lessons to be learned for the UK January 31 2020 https://drugscience.org.uk/wp-content/uploads/2020/01/Full-Report.pdf Related ContentProject Twenty21 - August UpdateAugust 17, 2022Project Twenty21 - July UpdateJuly 12, 2022Cannabinoids and the endocannabinoid system in fibromyalgia: a review of preclinical and clinical researchJune 21, 2022Project Twenty21 - June UpdateJune 15, 2022Characteristics of People Seeking Prescribed Cannabinoids for the Treatment of Chronic Pain: Evidence From Project Twenty 21June 13, 2022Are you looking for more information about our Long COVID study?June 8, 2022Project Twenty21 - May UpdateMay 12, 2022Farmability and pharmability: Transforming the drug market to a health-and human rights-centred approach from self-cultivation to safe supply of controlled substancesMay 11, 2022Project Twenty21 - April UpdateApril 15, 2022Project Twenty21 - March UpdateMarch 18, 2022Project Twenty21 - February UpdateFebruary 21, 2022Medical Cannabis Prescribing for GPsFebruary 4, 2022